MRC2 and neoplasm: Although Endo180 is expressed by some sarcomas24, glioblastomas25 and metaplastic breast cancers26, in most solid tumours of epithelial origin, expression of Endo180 is reported to be predominantly restricted to CAFs with little or no expression by the tumour cells27–30.